ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,246.95
0.18%
Dow Jones
38,807.33
0.25%
Gold vs US Dollar
2,368.385
0.57%
Brent Oil
78.615
0.07%
Bitcoin
71,074.85
0.00%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Insmed Inc (INSM)

  7. Insmed Inc (INSM) News

Insmed (INSM)

Insmed Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateTimeSourceHeadlineSymbolCompany
05/06/202421:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
05/06/202413:00PR Newswire (US)Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:INSMInsmed Inc
04/06/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INSMInsmed Inc
03/06/202421:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
30/05/202422:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
30/05/202422:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
30/05/202422:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
30/05/202422:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
30/05/202422:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
30/05/202422:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INSMInsmed Inc
30/05/202421:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
30/05/202421:05PR Newswire (US)Insmed to Host Commercial Webinar on June 4, 2024NASDAQ:INSMInsmed Inc
30/05/202421:02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INSMInsmed Inc
30/05/202413:00PR Newswire (US)Insmed Announces Pricing of $650 Million Public Offering of Common StockNASDAQ:INSMInsmed Inc
28/05/202423:21PR Newswire (US)Insmed Announces Proposed $500 Million Public Offering of Common StockNASDAQ:INSMInsmed Inc
28/05/202421:51Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
28/05/202421:49Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
28/05/202421:47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
28/05/202421:46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
28/05/202421:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
28/05/202421:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
28/05/202411:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INSMInsmed Inc
28/05/202411:30PR Newswire (US)Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with BronchiectasisNASDAQ:INSMInsmed Inc
28/05/202411:30PR Newswire (US)Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with BronchiectasisNASDAQ:INSMInsmed Inc
27/05/202421:00PR Newswire (US)Insmed to Host Investor Call to Discuss Topline Results from Phase 3 ASPEN Study of Brensocatib in Patients with BronchiectasisNASDAQ:INSMInsmed Inc
20/05/202421:28PR Newswire (US)Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 International ConfeNASDAQ:INSMInsmed Inc
17/05/202421:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
17/05/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
15/05/202421:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
15/05/202421:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM

Your Recent History

LSE
SVG
NASDAQ
PIIIW
P3 Partners
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved